Table 3.
Association between hepatic infection and colorectal polyp in gender difference
| Gender | Variables |
Model
a
1
OR (95% CI) |
P Value |
Model
a
2
OR (95% CI) |
P Value |
Model
a
3
OR (95% CI) |
P Value |
|---|---|---|---|---|---|---|---|
| Male | All | ||||||
| Uninfected | reference | - | reference | - | reference | - | |
| HCV | 0.66 (0.46-0.94) | 0.021 | 0.61 (0.42-0.87) | 0.007 | 0.60 (0.42-0.87) | 0.006 | |
| HBV | 0.98 (0.75-1.30) | 0.908 | 1.08 (0.81-1.43) | 0.618 | 1.09 (0.82-1.46) | 0.560 | |
| HCV+HBV | 1.28 (0.65-2.52) | 0.483 | 1.28 (0.63-2.58) | 0.493 | 1.20 (0.59-2.43) | 0.615 | |
| Female | Uninfected | reference | - | reference | - | reference | - |
| HCV | 0.93 (0.56-1.54) | 0.783 | 0.92 (0.55-1.53) | 0.745 | 0.90 (0.54-1.50) | 0.684 | |
| HBV | 1.13 (0.72-1.79) | 0.588 | 1.26 (0.79-2.02) | 0.326 | 1.25 (0.78-2.01) | 0.346 | |
| HCV+HBV | 1.26 (0.49-3.23) | 0.627 | 1.32 (0.50-3.46) | 0.573 | 1.28 (0.49-3.37) | 0.620 | |
| Tubular adenoma | |||||||
| Male | Uninfected | reference | - | reference | - | reference | - |
| HCV | 0.87 (0.52-1.46) | 0.591 | 0.76 (0.45-1.30) | 0.321 | 0.77 (0.45-1.32) | 0.345 | |
| HBV | 0.70 (0.44-1.12) | 0.136 | 0.75 (0.46-1.20) | 0.227 | 0.76 (0.47-1.22) | 0.261 | |
| HCV+HBV | 2.21 (0.95-5.13) | 0.065 | 2.28 (0.96-5.41) | 0.063 | 2.22 (0.93-5.33) | 0.071 | |
| Female | Uninfected | reference | - | reference | - | reference | - |
| HCV | 0.68 (0.29-1.59) | 0.376 | 0.68 (0.62-1.59) | 0.372 | 0.66 (0.28-1.55) | 0.346 | |
| HBV | 1.34 (0.73-2.43) | 0.343 | 1.46 (0.79-2.70) | 0.221 | 1.48 (0.80-2.72) | 0.213 | |
| HCV+HBV | 0.56 (0.08-4.14) | 0.569 | 0.62 (0.08-4.62) | 0.637 | 0.59 (0.08-4.48) | 0.614 | |
| Hyperplastic polyp | |||||||
| Male | Uninfected | reference | - | reference | - | reference | - |
| HCV | 0.87 (0.45-1.69) | 0.686 | 0.81 (0.41-1.58) | 0.537 | 0.83 (0.42-1.63) | 0.592 | |
| HBV | 1.00 (0.59-1.68) | 0.989 | 1.05 (0.62-1.79) | 0.845 | 1.08 (0.63-1.84) | 0.775 | |
| HCV+HBV | 0.95 (0.22-4.00) | 0.943 | 0.94 (0.22-4.00) | 0.931 | 0.90 (0.21-3.85) | 0.889 | |
| Female | Uninfected | reference | - | reference | - | reference | - |
| HCV | 0.66 (0.21-2.15) | 0.493 | 0.64 (0.19-2.08) | 0.454 | 0.61 (0.19-2.02) | 0.421 | |
| HBV | 0.77 (0.28-2.16) | 0.620 | 0.81 (0.28-2.31) | 0.693 | 0.80 (0.28-2.29) | 0.674 | |
| HCV+HBV | 1.11 (0.15-8.26) | 0.922 | 0.95 (0.12-7.64) | 0.961 | 0.91 (0.11-7.11) | 0.928 | |
a Adjusted covariates:
Model 1 = unadjusted
Model 2 = Model 1 + age, BMI, proteinuria, serum total cholesterol, uric acid, creatinine, AST, albumin, hsCRP, TSH
Model 3 = Model 2 + history of smoking, drinking